5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tackling diversity in prostate cancer clinical trials: A report from the Diversity Working Group of the IRONMAN registry
    Journal Article

    McKay, R. R.; Gold, T.; Zarif, J. C.; Chowdhury-Paulino, I. M.; Friedant, A.; Gerke, T.; Grant, M.; Hawthorne, K.; Heath, E.; Huang, F. W.; more...
    JCO Global Oncology (2021)

    Fulltext@MSK | Save
  • Seek and find: Current prospective evidence for prostate-specific membrane antigen imaging to detect recurrent prostate cancer
    Review

    Keegan, N. M.; Bodei, L.; Morris, M. J.
    European Urology Focus (2021)

    Fulltext@MSK | Save
  • Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer
    Journal Article

    Scher, H. I.; Armstrong, A. J.; Schonhoft, J. D.; Gill, A.; Zhao, J. L.; Barnett, E.; Carbone, E.; Lu, J.; Antonarakis, E. S.; Luo, J.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Ceralasertib (cer) in combination with olaparib (ola) in patients (pts) with advanced breast cancer (BC): Results of phase I expansion cohorts
    Meeting Abstract

    Dean, E.; Krebs, M. G.; Im, S. A.; Campone, M.; Postel-Vinay, S.; Arkenau, T.; Lopez, J.; Abida, W.; Jodrell, D.; Lee, K. W.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Pleiotropic mechanisms drive endocrine resistance in the three-dimensional bone microenvironment
    Journal Article

    Dhimolea, E.; de Matos Simoes, R.; Kansara, D.; Weng, X.; Sharma, S.; Awate, P.; Liu, Z.; Gao, D.; Mitsiades, N.; Schwab, J. H.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Estimand framework: Are we asking the right questions? A case study in the solid tumor setting
    Journal Article

    Casey, M.; Degtyarev, E.; Lechuga, M. J.; Aimone, P.; Ravaud, A.; Motzer, R. J.; Liu, F.; Stalbovskaya, V.; Tang, R.; Butler, E.; more...
    Pharmaceutical Statistics (2021)

    Fulltext@MSK | Save
  • A genomic-pathologic annotated risk model to predict recurrence in early-stage lung adenocarcinoma
    Journal Article

    Jones, G. D.; Brandt, W. S.; Shen, R.; Sanchez-Vega, F.; Tan, K. S.; Martin, A.; Zhou, J.; Berger, M.; Solit, D. B.; Schultz, N.; more...
    JAMA Surgery (2021)

    Fulltext@MSK | Save
  • Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer
    Journal Article

    Gartrell, B. A.; Roach, M. 3rd; Retter, A.; Sokol, G. H.; Del Priore, G.; Scher, H. I.
    Investigational New Drugs (2021)

    Fulltext@MSK | Save
  • A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tract
    Journal Article

    Sarfaty, M.; Whiting, K.; Teo, M. Y.; Lee, C. H.; Peters, V.; Durocher, J.; Regazzi, A. M.; McCoy, A. S.; Hettich, G.; Jungbluth, A. A.; more...
    Cancer Medicine (2021)

    Fulltext@MSK | Save